Bae ES,Byun WS,Ock CW,Kim WK,Park HJ,Lee SK .2023 .Periplocin exerts antitumor activity by regulating nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Biomed Pharmacother, 157 : 114039.
Bloise E,Braca A,De Tommasi N and Belisario MA .2009 .Pro-apoptotic and cytostatic activity of naturally occurring cardenolides. Cancer Chemother Pharmacol., 64 : 793-802.
Cappellesso F,Orban MP,Shirgaonkar N,Berardi E,Serneels J,Neveu MA,Di Molfetta D,Piccapane F,Caroppo R,Debellis L,Ostyn T,Joudiou N,Mignion L,Richiardone E,Jordan BF,Gallez B,Corbet C,Roskams T,Dasgupta R,Tejpar S,Di Matteo M,Taverna D,Reshkin SJ,Topal B,Virga F,Mazzone M .2022 .Targeting the bicarbonate transporter slc4a4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Nat Cancer, 3 : 1464-1483.
Feng Z,Ye Z,Xie J,Chen W,Li W,Xing C .2021 .Study on the mechanism of loxl1-as1/mir-3614-5p/yy1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma. Biol Direct, 16 : 24.
Fu XP,Ji CY,Tang WQ,Yu TT,Luo L TT,Non-Coding Rna TT .2024 .-As1: A potential biomarker and therapeutic target in human malignant tumors. Clin. Exp. Med, 24 : 93.
Gandaglia G,Karakiewicz PI,Briganti A,Passoni NM,Schiffmann J,Trudeau V,Graefen M,Montorsi F,Sun M .2015 .Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur. Urol., 68 : 325-34.
Guccini I,Revandkar A,D'ambrosio M,Colucci M,Pasquini E,Mosole S,Troiani M,Brina D,SheibaniTezerji R,Elia AR,Rinaldi A,Pernigoni N,Ruschoff J H,Dettwiler S,De Marzo AM,Antonarakis ES,Borrelli C,Moor AE,Garcia-Escudero R,Alajati A,Attanasio G,Losa M,Moch H,Wild P,Egger G,Alimonti A .2021 .Senescence reprogramming by timp1 deficiency promotes prostate cancer metastasis. Cancer Cell, 39 : 68-82.
Guo S,Ma B,Jiang X,Li X,Jia Y .2020 .Astragalus polysaccharides inhibits tumorigenesis and lipid metabolism through mir-138-5p/sirt1/srebp1 pathway in prostate cancer. Front Pharmacol, 11 : 598.
Han L,Sun Y,Lu C,Ma C,Shi J,Sun D J .2021 .Mir3614-5p is a potential novel biomarker for colorectal cancer. Front Genet, 12 : 666833.
Hao J,Chang L,Wang D,Ji C,Zhang S,Hou Y,Wu Y Y .2023 .Periplocin alleviates cardiac remodeling in doca-salt-induced heart failure rats. J Cardiovasc Transl Res., 16 : 127-140.
Hsieh YH,Yu FJ,Nassef Y,Liu CJ,Chen YS,Lin CY,Feng JL,Wu MH .2022 .Targeting of mcl-1 expression by mirna-3614-5p promotes cell apoptosis of human prostate cancer cells. Int. J. Mol. Sci, 23 : 4194.
Hussen BM,Hidayat HJ,Salihi A,Sabir DK,Taheri M,Ghafouri-Fard S .2021 .Microrna: A signature for cancer progression. Biomed Pharmacother, 138 : 111528.
Khanmi K,Ignacimuthu S,Paulraj MG .2015 .. Clin Chim Acta, 451 : 154-60.
Lacouture A,Lafront C,Peillex C,Pelletier M and AudetWalsh E C .2022 .Impacts of endocrine-disrupting chemicals on prostate function and cancer. Environ Res., 204 : 112085.
Li F,Yang H,Kong T,Chen S,Li P,Chen L,Cheng J,Cui G,Zhang G .2020 .Pgam1, regulated by mir-3614- 5p, functions as an oncogene by activating transforming growth factor-beta (tgf-beta) signaling in the progression of non-small cell lung carcinoma. Cell Death Dis., 11 : 710.
Li Y,Li J,Zhou K,He J,Cao J,An M,Chang YX M .2016 .A review on phytochemistry and pharmacology of cortex periplocae. Molecules, 21 : 1702.
Lin JP,Huang MH,Sun ZT,Chen L,Lei YH,Huang Y Q,Qi M,Fan SR,Chung SG,Chan CW,Liu MC,Hu JS,Chen M,Ye MF,Chen WC,Deng YY,LJ YY .2023 .Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of mdscs through akt/nf-kappab pathway. Life Sci, 324 : 121715.
Liu J,Dong L,Zhu Y,Dong B,Sha J,Zhu HH,Pan J,Xue W (2022a). Prostate Cancer Treatment - China's Perspective J . .. Cancer Lett., 550 : 215927.
Lotan TL,Tomlins SA,Bismar TA,Van Der Kwast TH,Grignon D,Egevad L,Kristiansen G,Pritchard CC,Rubin MA,Bubendorf L MA .2020 .Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers. I. molecular biomarkers in prostate cancer. Am. J. Surg Pathol, 44 : E15-E29.
Luo H,Vong CT,Chen H,Gao Y,Lyu P,Qiu L,Zhao M,Liu Q,Cheng Z,Zou J,Yao P,Gao C,Wei J,Ung CO L,Wang S,Zhong Z,Wang Y .2019 .Naturally occurring anti-cancer compounds: Shining from chinese herbal medicine. Chin Med, 14 : 48.
Markowski MC,Carducci MA .2017 .Early use of chemotherapy in metastatic prostate cancer. Cancer Treat Rev., 55 : 218-224.
Shang J,Wang Z,Chen W,Yang Z,Zheng L,Wang S,Li S S .2019 .Pseudogene chiap2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the wnt pathway. J Cell Physiol, 234 : 13735-13746.
Sharma K. K.,Gupta S.,Bisen P. S. .2025 .Enhancing Gastrointеstinal (GI) Cancer therapies with ganoderma lucidum: A review of mechanisms and efficacy. J Can Biomol Therap, 2 : 15-44.
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Bray F A .2020 .Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Global cancer statistics, 71 : 209-249.
Wang G,Zhao D,Spring DJ,Depinho RA .2018 .Genetics and biology of prostate cancer. Genes Dev, 32 : 1105-1140.
Wang K,Fu S,Dong L,Zhang D,Wang M,Wu X,Shen E,Luo L,Li C,Nice EC,Huang C,Zou B C .2023 .Periplocin suppresses the growth of colorectal cancer cells by triggering Lgals3 (Galectin 3)-Mediated Lysophagy. , 19 : 3132-3150.
Wang Z,Tong D,Han C,Zhao Z,Wang X,Jiang T,Li Q,Liu S,Chen L,Chen Y,Li A,Huang C .2019 .Blockade of Mir-3614 maturation by Igf2bp3 Increases Trim25 expression and promotes breast cancer cell proliferation. , 41 : 357-369.
Xia C,Dong X,Li H,Cao M,Sun D,He S,Yang F,Yan X,Zhang S,Li N,Chen W .2022 .. Chin Med J (Engl), 135 : 584-590.
Xie G,Sun L,Li Y,Chen B,Wang C .2021 .Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via Ampk-Mtor signaling. Cancer Med, 10 : 325-336.
Xu W,Ding J,Li B,Sun T,You X,He Q,Sheng W .2023 .Effects of icariin and curcumol on autophagy, ferroptosis and lipid metabolism based on mir-7/mtor/srebp1 pathway on prostate cancer. Biofactors., 49 : 438-456.
Yao H,Zhou X,Zhou A,Chen J,Chen G,Shi X,Shi B,Tai Q,Mi X,Zhou G,Wang S,Sun J,Yang X,Yang Y,Cao H,Zhou D,Sun L.,Yao Y,He S Y .2023 .Functions as an oncogene in the progression of colorectal cancer. Mol. Carcinog, 62 : 771-785.
Yu C,Li H,Zhang C,Tang Y,Huang Y,Lu H,Jin K,Zhou J,Yang J .2024 .Solute carrier family 4 member 4 (slc4a4) is associated with cell proliferation, migration and immune cell infiltration in colon cancer. Discov Oncol., 15 : 597.
Yue Y,Tan M,Luo Y,Deng P,Wang H,Li J,Hao R,Tian L,Xie J,Chen M,Yu Z,Zhou Z,Pi H Z .2022 .Mir3614-5p downregulation promotes cadmium-induced breast cancer cell proliferation and metastasis by targeting txnrd1. Ecotoxicol Environ Saf, 247 : 114270.
Zhang X,Qiu H,Li C,Cai P,Qi F P .2021 .The positive role of traditional chinese medicine as an adjunctive therapy for cancer. Biosci Trends, 15 : 283-298.
Zhou J,Jiang YY,Chen H,Wu YC,Zhang L YC .2020 .Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of pi3k/akt/mtor pathway. Cell Prolif, 53 : E12739.